MedPath

PARTH PATEL

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Phase 4
Active, not recruiting
Conditions
Central Nervous System Embryonal Tumors
Medulloblastoma
Interventions
Drug: Induction
Drug: Single Cycle Intensive Chemotherapy
First Posted Date
2016-08-23
Last Posted Date
2025-08-24
Lead Sponsor
Parth Patel
Target Recruit Count
250
Registration Number
NCT02875314
Locations
🇺🇸

Children's of Alabama, Birmingham, Alabama, United States

🇺🇸

Phoenix Children's Hospital, Phoenix, Arizona, United States

🇺🇸

Arkansas Children's Hospital, Little Rock, Arkansas, United States

and more 58 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.